DPP-4 inhibitors: consensus statement published on Diabetes Care. Diagram of its mechanism of action.

Below is a transcript of the latest statement (December 2008) published on Diabetes Care about the role of dipeptidyl peptidase four inhibitors in the medical management of hyperglycemia in type 2 diabetes. Dipeptidyl peptidase four inhibitors. GLP-1 and glucose-dependent insulinotropic peptide (GIP), the main insulinotropic peptides of intestinal origin (incretins), are rapidly degraded by dipeptidyl peptidase four (DPP-4). […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos